Blocking cannabinoid receptors reversed memory problems caused by ecstasy withdrawal in mice
A cannabinoid CB1 receptor antagonist (AM251) reversed recognition memory impairment during MDMA withdrawal in mice, linked to increased CB1 receptor protein in the hippocampus.
Quick Facts
What This Study Found
Mice received MDMA (ecstasy) daily for 7 days. On the 7th day of withdrawal, recognition memory was significantly impaired in a novel object recognition test.
The cannabinoid CB1 receptor antagonist AM251 blocked this memory impairment when given either before the test or alongside MDMA during the treatment period. CB1 receptor protein levels increased significantly in the hippocampus during MDMA withdrawal, but not in the prefrontal cortex or striatum.
Co-administration of AM251 with MDMA prevented the hippocampal CB1 receptor increase. Additionally, CB1 receptor knockout mice showed no recognition memory impairment during MDMA withdrawal, confirming the role of CB1 receptors in this effect.
Key Numbers
MDMA dose: 10 mg/kg daily for 7 days. Memory tested at withdrawal day 7. CB1 protein increased significantly in hippocampus but not prefrontal cortex or striatum.
How They Did This
Controlled animal study in mice. MDMA (10 mg/kg i.p.) administered daily for 7 days. Novel object recognition test performed on withdrawal day 7. CB1 receptor protein measured by western blotting. Multiple experimental conditions tested: AM251 before testing, AM251 co-administered with MDMA, and CB1 knockout mice.
Why This Research Matters
The study identified the endocannabinoid system as a key mediator of memory impairment during MDMA withdrawal, potentially opening therapeutic targets for cognitive recovery in ecstasy users.
The Bigger Picture
This research connected ecstasy-related cognitive problems to the endocannabinoid system, adding to understanding of how different drug systems interact in the brain during withdrawal.
What This Study Doesn't Tell Us
Mouse model using high daily MDMA doses that may not reflect human recreational use patterns. The novel object recognition test captures only one type of memory. Withdrawal period was limited to 7 days.
Questions This Raises
- ?Would CB1 antagonists help ecstasy users recover cognitive function?
- ?Do similar endocannabinoid changes occur in the human hippocampus during MDMA withdrawal?
Trust & Context
- Key Stat:
- CB1 knockout mice showed no memory impairment during MDMA withdrawal
- Evidence Grade:
- Well-controlled animal study with multiple experimental conditions and knockout confirmation, but limited to mouse models.
- Study Age:
- Published in 2010. Research on cross-drug interactions involving the endocannabinoid system has continued.
- Original Title:
- A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
- Published In:
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35(2), 515-20 (2010)
- Authors:
- Nawata, Yoko, Hiranita, Takato(3), Yamamoto, Tsuneyuki(2)
- Database ID:
- RTHC-00437
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What does this have to do with cannabis?
The study focused on cannabinoid CB1 receptors, which are the same receptors activated by THC in cannabis. MDMA withdrawal upregulated these receptors in the hippocampus, causing memory problems.
Could this help people who have used ecstasy?
The findings suggest CB1 receptor antagonists might help reverse cognitive impairment from MDMA use, but this has not been tested in humans.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00437APA
Nawata, Yoko; Hiranita, Takato; Yamamoto, Tsuneyuki. (2010). A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35(2), 515-20. https://doi.org/10.1038/npp.2009.158
MLA
Nawata, Yoko, et al. "A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. https://doi.org/10.1038/npp.2009.158
RethinkTHC
RethinkTHC Research Database. "A cannabinoid CB(1) receptor antagonist ameliorates impairme..." RTHC-00437. Retrieved from https://rethinkthc.com/research/nawata-2010-a-cannabinoid-cb1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.